Sort
261,768 grants matching “gene therapy”
Role of CEBP transcription factors in cell growth and tumorigenesis
$1,390,451Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Molecular Mechanisms of Fate Choice in Neural Stem Cells
$1,390,424Dana-Farber Cancer Institute · P01 · FY2005 · NS
Functional Mechanisms of T1D Risk Variants and their Target Genes using 3D Epigenomics and Single Cell Approaches
$1,390,253Stephen S. Rich · University Of Virginia · R01 · FY2020 · DK
NIDCD Core for Clinical Research and Care
$1,390,194Carter Van Waes · National Institute On Deafness And Other Communication Disorders · ZID · FY2012 · DC
Finding Genes for Human Prostate Cancer
$1,390,024Elaine Ostrander · National Human Genome Research Institute · ZIA · FY2013 · HG
CureSC Manufacturing Resource Platform
$1,389,793Angelo A. Cardoso · Beckman Research Institute/City Of Hope · OT3 · FY2023 · HL
Molecular and cellular mechanisms of the FVIII immune response
$1,389,453Rodney M Camire · Children'S Hosp Of Philadelphia · U54 · FY2022 · HL
Multiscale Analysis of Immune Responses
$1,389,263Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study
$1,389,219Christine M Albert · Brigham And Women'S Hospital · R01 · FY2010 · HL
Pharmacogenomics of ART adherence and effectiveness in the ALIVE Cohort
$1,389,208Brion S Maher · Johns Hopkins University · R01 · FY2018 · DA
Role of co-receptor modified cells in HIV infection
$1,388,771Carl H. June · University Of Pennsylvania · U01 · FY2016 · AI
Modulation of Therapeutic Response
$1,388,770James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Leukemia Signatures for Risk Classification & Targeting
$1,388,594Cheryl L Willman · University Of New Mexico · U01 · FY2007 · CA
Leukemia Signatures for Risk Classification & Targeting
$1,388,417Cheryl L Willman · University Of New Mexico · U01 · FY2006 · CA
NEW THERAPIES FOR HEMOPHILIA
$1,388,152University Of Minnesota Twin Cities · P01 · FY2002 · HL
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,388,137Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
MACROPHAGES, DENDRITIC CELLS AND PATHOGENS
$1,388,080Weill Medical College Of Cornell Univ · P01 · FY2005 · AI
ADP-ribosylation Cycles
$1,388,014Joel Moss · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
Regulation And Function Of Retroelements
$1,388,000Henry L. Levin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2015 · HD
Extracellular Vesicles (EVs) and Genes in the Biology and Therapy of Gliomas
$1,387,951Xandra Owens Breakefield · Massachusetts General Hospital · P01 · FY2017 · CA
Mir-29 mimicry as a therapy for pulmonary fibrosis
$1,387,947Naftali Kaminski · Yale University · UH3 · FY2018 · HL
Biomarkers for Therapy of FSHD (U54)
$1,387,935Charles P Emerson · Univ Of Massachusetts Med Sch Worcester · U54 · FY2017 · HD
Center for Genetics, Genomics, and Epigenetics of Substance Use Disorders in Outbred Rats
$1,387,925Abraham A Palmer · University Of California, San Diego · P30 · FY2025 · DA
Bio-Analysis Core
$1,387,892George A Kuchel · University Of Connecticut Sch Of Med/Dnt · U54 · FY2023 · AG
Cancer-cell specific therapy: photo-immunotherapy
$1,387,661Hisataka Kobayashi · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA